Kim, J., Kim, H., Lee, J., Kim, J. W., Paik, W. H., Lee, S. H., . . . Kim, Y. (2018). Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer. PLoS One.

Kim, Jaihwan, Haeryoung Kim, Jong-chan Lee, Jin Won Kim, Woo Hyun Paik, Sang Hyub Lee, Jin-Hyeok Hwang, Ji Kon Ryu, et Yong-Tae Kim. "Human Equilibrative Nucleoside Transporter 1 (hENT1) Expression As a Predictive Biomarker for Gemcitabine Chemotherapy in Biliary Tract Cancer." PLoS One 2018.

Kim, Jaihwan, et al. "Human Equilibrative Nucleoside Transporter 1 (hENT1) Expression As a Predictive Biomarker for Gemcitabine Chemotherapy in Biliary Tract Cancer." PLoS One 2018.